A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women - Wikidata - awgldk - TriplyDB

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

http://www.wikidata.org/entity/Q30052389

about

Role of human papillomaviruses in carcinogenesis Update on the new 9-valent vaccine for human papillomavirus prevention Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination The Promise of Preventive Cancer Vaccines Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa Targeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for Therapy Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement HPV infection and vaccination in Systemic Lupus Erythematosus patients: what we really should know Major clinical research advances in gynecologic cancer in 2015 Current global status & impact of human papillomavirus vaccination: Implications for India Summary of emerging targets in anal cancer: the case for an immunotherapy based-approach Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.Age-specific prevalence of HPV16/18 genotypes in cervical cancer: A systematic review and meta-analysis.Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland hrHPV E5 oncoprotein: immune evasion and related immunotherapies.Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types.Human papillomavirus vaccination: the population impact.Comprehensive Human Papillomavirus Genotyping in Cervical Squamous Cell Carcinomas and Its Relevance to Cervical Cancer Prevention in Malawian Women Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia.Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy.A population-based study of cervical cytology findings and human papillomavirus infection in a suburban area of Thailand Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions.Systematic review of model-based cervical screening evaluations.Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies Immunologic Control of Mus musculus Papillomavirus Type 1.Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status.Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine.

P2860

Q22305628-FF18FEF3-AD09-4E2B-80C8-6B506CBC2E19 Q26743630-BBE4CEFC-6DBC-4447-BD4E-E6291F480663 Q26745696-F011BF4F-3FA8-4857-8C72-E2556B963750 Q26766348-837D39E2-5E8B-4D8C-A814-DB12A18C10ED Q26783742-143F2D93-4A79-4B05-B79E-E3B083AE360B Q26783973-ED7935CF-A866-44A3-8BEE-55E398BB568A Q26799584-88754534-B7A2-425A-9784-50FEEE7BD085 Q26824925-1ABFFD3B-49E2-4782-9C37-F5FEB03229DB Q28069669-2569600B-74C3-44F0-974C-56395F923259 Q28072958-D6A9C053-540C-4BF0-BC17-6C80E3F5965A Q28077183-9CD9DE4C-44AE-4FF4-95B9-C84232C669BF Q28079776-85D33547-B59E-4634-B566-DA88E5E5A1BE Q28080081-5ED92B8E-EE92-4A5F-A4C4-9838CE7EC3DB Q28088322-6F3EF359-B636-41FE-862B-6B9DEE8E1374 Q28603888-FB1532D9-AE84-40E8-A617-991ED68FBAC4 Q30238649-FD0D999E-B0E4-4125-8B82-A3B7BCF18158 Q30251408-1BB5086C-3968-47DD-A856-6F803CCDE9BF Q30251868-A8412CFE-6B6D-49C1-84A3-5FA69B42B6C6 Q30252012-22927D1F-FDD3-46B4-8438-E2FF4F69CCB0 Q30970916-A3273977-7795-432A-9F27-BD56FA166455 Q31115877-3EE992D9-6DA1-4CAA-9332-610307C7C6CF Q33713018-C6A84C55-97BE-4620-899F-9E18F6E57E78 Q33730462-0D1AB522-C050-4283-8978-54D05030668B Q33757466-2EBA85E1-33E8-464C-9AAC-FCFDAA3F8A8D Q33774640-D305BC60-0F9A-475E-B452-30B3E5B8C04F Q33806566-54E7316B-8031-41E9-B709-4FD9480D0EF7 Q33859491-B8005A1A-8F68-4910-AF85-DE315873F426 Q33888215-E9000FAE-9D95-4AEE-8BBF-02615F9FC423 Q33892348-E31E81A1-215F-4ED1-9B46-0B185750CA79 Q33897057-6B23A543-61C1-46F5-AAEA-E8A6D7AB375A Q33907700-0B2D6050-BEA0-4E03-B615-D2E7D6C06F34 Q34507291-E5D55488-BFCD-40FD-A263-694D6A9ED88E Q35568922-C42832EF-8863-4BE3-B26C-55FD64F8DD8B Q35743733-33AA8668-0026-4A7B-911C-43F7CDF80291 Q35773930-6C34228D-CE76-4483-BFB9-651A6FF3A60D Q35818624-B5A53BED-37BF-4A8F-8AB7-D62CAC3FC65A Q35818648-109B7269-8DD7-4D20-83A0-1D65E87CEF95 Q35821601-3482E4C7-DD08-487A-B8AC-9751924039E6 Q35861286-C94E57BC-CB95-44F0-94F7-0F609B61CC01 Q35887407-D87E8874-373E-4997-9B60-A5B040601684

P2860

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

http://www.wikidata.org/entity/Q30052389

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

@ast

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

@en

type

label

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

@ast

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

@en

prefLabel

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

@ast

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

@en

P1433

Q30052389-9C9081FE-0CE1-4B1D-9DAE-34A171FC3BF7

P1476

Q30052389-61A61052-BA4E-4702-9E1F-E8622DCA3566

P2093

Q30052389-0B274D64-0705-49C4-987C-8F60B92FBBD6

Q30052389-0DD7EEB0-153C-4F00-BA45-0722D729EF91

Q30052389-206D5B50-F9DC-4DEB-A80F-D257836D2CFC

Q30052389-31178397-FEA6-4307-BC1C-348A7FC6C53A

Q30052389-37A40E61-A6EC-4766-A97A-770B84220F22

Q30052389-38BD56B1-9900-429E-82BE-FA96B8AC99EF

Q30052389-3C1AA1E8-666E-4E32-ABEB-67A66D0E1E23

Q30052389-3C74E816-CB3A-4E25-8E9E-C9E4A6717D41

Q30052389-3E917C7F-C68D-482E-8D09-0F54202A1A47

Q30052389-4D707865-99C7-40B4-9649-1CD54729D69E

P304

Q30052389-0A8CCC0D-CA66-48A2-8312-61BE2940F435

P31

Q30052389-8AB8B6C7-C4FC-472C-A7A3-5C56FFC0BC51

P3181

Q30052389-0EE2482A-6F9B-4696-AC7A-F12FA90648CD

P356

Q30052389-51AA8EA3-84F5-4C0D-B5D2-6F65F014458C

P407

Q30052389-5C5F2B4B-31DA-4240-BEBD-4EBE2A4495FA

P433

Q30052389-DA2AB556-5116-4610-A45B-60BD210CB33B

P478

Q30052389-337D3E42-EA84-41C6-B48D-44134B76ACF5

P577

Q30052389-9BA2225C-6EC3-4EE7-BA11-750FD623A1CF

P5875

Q30052389-AF6A36AD-6588-48BA-A8AD-FA612FE86BF6

P698

Q30052389-4D4B2002-0326-4BBF-BA78-E335B64398C6

P3181

P356

P1433

The New England Journal of Medicine

P1476

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

@en

P2093

Alain Luxembourg

http://www.w3.org/2001/XMLSchema#string

Anna R. Giuliano

http://www.w3.org/2001/XMLSchema#string

Celine Bouchard

http://www.w3.org/2001/XMLSchema#string

Constance Mao

http://www.w3.org/2001/XMLSchema#string

Edson D. Moreira

http://www.w3.org/2001/XMLSchema#string

Eduardo Lazcano-Ponce

http://www.w3.org/2001/XMLSchema#string

Elmar A. Joura

http://www.w3.org/2001/XMLSchema#string

Erin Moeller

http://www.w3.org/2001/XMLSchema#string

Gavin Stuart

http://www.w3.org/2001/XMLSchema#string

Ivan S.F. Chan

http://www.w3.org/2001/XMLSchema#string

P304

711-723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1123015

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA1405044

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

372

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272510453

http://www.w3.org/2001/XMLSchema#string

P698

25693011

http://www.w3.org/2001/XMLSchema#string